Which of the following phrases most logically completes the passage below?
Cevap:In recent years, several major pharmaceutical firms have transitioned from fixed-fee manufacturing contracts to outcome-based pricing models for newly approved rare-disease therapies, reimbursing healthcare providers if a drug fails to produce measurable clinical efficacy within six months. While proponents argued that this shift would incentivize drugmakers to release only highly effective treatments, industry analysts note that developing diagnostic tests to reliably verify six-month clinical efficacy requires substantial upfront capital that small biotech firms cannot afford. Consequently, if third-party insurers demand outcome-based pricing across all rare-disease therapies, small biotech developers will likely be forced to license their experimental compounds to large pharmaceutical conglomerates long before clinical trials conclude, thereby 【consolidating market control of innovative rare-disease drugs within large pharmaceutical conglomerates】.
Cevap
The passage is most logically completed by indicating that mandatory outcome-based pricing will consolidate market dominance and commercialization control within large pharmaceutical conglomerates while preventing small biotechs from bringing therapies to market independently.
The correct logical completion must bridge the shift from biotechs being unable to fund diagnostic testing to their forced licensing of compounds to large pharmaceutical conglomerates. Early licensing deprives small biotechs of direct commercialization, thereby entrenching and consolidating market control of innovative rare-disease treatments within large pharmaceutical conglomerates.
Adım Adım Çözüm
Anahtar Kavram
Completing the Passage Logically